Exploring cancer patients', caregivers', and clinicians' utilisation and experiences of telehealth services during COVID-19: A qualitative study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: Ireland NLM ID: 8406280 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5134 (Electronic) Linking ISSN: 07383991 NLM ISO Abbreviation: Patient Educ Couns
    • Publication Information:
      Publication: Limerick : Elsevier
      Original Publication: Princeton, N.J. : Excerpta Medica, c1983-
    • Subject Terms:
      COVID-19*/epidemiology ; Neoplasms*/therapy ; Telemedicine*; Adult ; Australia ; Caregivers ; Humans ; Pandemics
    • Abstract:
      Objectives: The COVID-19 pandemic has significantly impacted oncology. With pandemic restrictions limiting close contact between individuals, telehealth (the use of teleconferencing/videoconferencing to conduct real-time medical consultations) has been increasingly utilised. This qualitative study aimed to explore adult cancer patient, caregiver, and clinician (doctor, nurse, allied health) telehealth experiences during COVID-19 in urban and rural Australian settings and identify potential enablers and barriers to sustained telehealth implementation.
      Methods: English-speaking participants completed semi-structured interviews regarding their telehealth experiences since March 2020. Interviews ceased when data saturation occurred. Iterative thematic analysis was conducted using NVivo 12 Pro.
      Results: Thirty-four interviews (clinician=14, patient=13, caregiver=7) were conducted from April to August 2021. Analysis generated seven themes relating to telehealth use: 1) Acceptability as a form of consultation, 2) Impacts on healthcare provision, 3) Communication & relationships, 4) Efficient form of consultation, 5) Comfort of conducting telehealth in different environments, 6) Technological barriers and 7) Future preferences.
      Conclusions: The rapid uptake of telehealth during the pandemic has mostly been well-received, and telehealth can be appropriately used in oncology.
      Practice Implications: Barriers including providing appropriate facilities, technology, and telehealth training; and selecting appropriate patients must be addressed to enable sustained telehealth use in future cancer care.
      Competing Interests: Declaration of Competing Interest The authors declare that there is no conflict of interest.
      (Copyright © 2022 Elsevier B.V. All rights reserved.)
    • References:
      Support Care Cancer. 2022 Jun;30(6):4769-4780. (PMID: 35141772)
      J Med Internet Res. 2020 Dec 10;22(12):e24531. (PMID: 33156806)
      Eur Urol Focus. 2020 Sep 15;6(5):1097-1103. (PMID: 32534969)
      Oncologist. 2021 Apr;26(4):e679-e685. (PMID: 33453121)
      J Med Internet Res. 2015 Mar 13;17(3):e65. (PMID: 25793945)
      Support Care Cancer. 2013 Apr;21(4):1201-7. (PMID: 23161339)
      Med J Aust. 2021 Apr;214(6):281-283. (PMID: 33624884)
      J Telemed Telecare. 2014 Mar 18;20(4):207-211. (PMID: 24643950)
      Oncol Nurs Forum. 2018 Sep 1;45(5):607-618. (PMID: 30118453)
      JAMA Netw Open. 2021 Jan 4;4(1):e2033967. (PMID: 33443581)
      Oncologist. 2020 Jun;25(6):e879-e880. (PMID: 32304624)
      BMC Fam Pract. 2021 Apr 8;22(1):69. (PMID: 33832422)
      J Telemed Telecare. 2012 Jul;18(5):297-300. (PMID: 22790013)
      Curr Oncol. 2021 Jan 22;28(1):671-677. (PMID: 33499380)
      Int J Med Inform. 2009 Nov;78(11):732-44. (PMID: 19620023)
      JCO Oncol Pract. 2021 Sep;17(9):e1333-e1343. (PMID: 34288697)
      Telemed J E Health. 2005 Oct;11(5):608-15. (PMID: 16250826)
      Telemed J E Health. 2018 Jun;24(6):397-405. (PMID: 29112484)
      Clin Transl Radiat Oncol. 2018 Nov 20;15:20-25. (PMID: 30582017)
      Palliat Med. 2008 Sep;22(6):768-74. (PMID: 18715977)
      Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):416-420. (PMID: 32890524)
      Eur J Cancer Care (Engl). 2017 Jan;26(1):. (PMID: 26931469)
      Psychooncology. 2015 Aug;24(8):857-70. (PMID: 25328103)
      Aust J Rural Health. 2012 Oct;20(5):265-9. (PMID: 22998201)
      Am J Hosp Palliat Care. 2019 Sep;36(9):789-794. (PMID: 31064195)
      J Breast Cancer. 2020 Oct 19;23(5):542-552. (PMID: 33154829)
      Future Oncol. 2021 May;17(13):1593-1600. (PMID: 33631995)
      Clin Soc Work J. 2021;49(4):463-470. (PMID: 33967352)
      JCO Oncol Pract. 2021 Sep;17(9):e1318-e1326. (PMID: 34264741)
      Surg Endosc. 2021 Mar;35(3):1278-1287. (PMID: 32198552)
      Cochrane Database Syst Rev. 2020 Jun 2;6:CD007568. (PMID: 32483832)
      Intern Med J. 2012 Jul;42(7):780-5. (PMID: 21627743)
      Psychooncology. 2017 Jun;26(6):770-778. (PMID: 27437905)
      J Cancer Educ. 2022 Oct;37(5):1429-1432. (PMID: 33851370)
      JCO Oncol Pract. 2021 Jan;17(1):e36-e43. (PMID: 33026951)
      Health Aff (Millwood). 2021 Mar;40(3):487-495. (PMID: 33646862)
      Otolaryngol Head Neck Surg. 2021 May;164(5):923-931. (PMID: 32662749)
      Tumori. 2022 Aug;108(4):357-363. (PMID: 33971749)
      Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):421-429. (PMID: 32890525)
      J Am Geriatr Soc. 2021 Nov;69(11):3034-3043. (PMID: 34245165)
      Indian J Palliat Care. 2020 Jun;26(Suppl 1):S40-S44. (PMID: 33088085)
      Oncologist. 2000;5(4):302-11. (PMID: 10964998)
      Psychooncology. 2017 Sep;26(9):1239-1253. (PMID: 28665554)
      CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
    • Contributed Indexing:
      Keywords: COVID-19; Cancer; Experiences; Qualitative; Telehealth
    • Publication Date:
      Date Created: 20220610 Date Completed: 20220908 Latest Revision: 20221221
    • Publication Date:
      20240628
    • Accession Number:
      PMC9170274
    • Accession Number:
      10.1016/j.pec.2022.06.001
    • Accession Number:
      35688719